Abstract #0129

Ferumoxytol-enhanced MRI: Early Results in Solid Organ Masses.

Puja Shahrouki^1,2, Woo Kyoung Jeong^1,3, Steven S. Raman¹, Ely R. Felker¹, David S. Lu¹, and J. Paul Finn^1,2

¹Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States, ²Diagnostic Cardiovascular Imaging Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States, ³Department of Radiology and Imaging Sciences, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Whereas experience is growing rapidly with the use of ferumoxytol as an alternative to gadolinium based contrast agents (GBCA) for cardiovascular imaging, little has been reported about its potential for imaging of solid organs. The pharmacokinetics and relaxometry of ferumoxytol are very different to all of the available GBCA, and data are lacking about its behavior in extracranial solid organ lesions. We report early results of FE-MR imaging in a variety of solid organ mass lesions with focus on enhancement characteristics and clinical impact.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.